Fetalix
Oporto
About Fetalix
Fetalix offers a regenerative fetal-inspired biomaterial aimed at treating Low Back Pain (LBP) through a minimally invasive procedure. The company is recognized as an EIT Health-supported start-up and recently received the SIFIDE certification from the Portuguese Agência, highlighting its innovative contributions to healthcare.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $424.9K
- Funding stage: Seed
- Last round: Grant (Sep 2025)
- Website: fetalix.eu
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/fetalix-86641 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.